Scholars Central

Research articlePublished 2022

Therapeutic Profile of Stroke Patients Managed with Neuroprotective Regimens

Authors: Ishaq Khan, Javeria Khan, Gazala Shams, Javed Shabbir

Stroke Research & Therapy

Volume 6 · Issue 4 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Development of safe and affective neuroprotective drugs for stroke management has been a medical subject for a number of years. Several clinical trials were withdrawn in vainness due to lack of optimum therapeutic outcomes. Nonetheless, recently a number of encouraging facts have highly supported demanding enthusiasm linked to management of stroke. Neuroprotectives have worked in growing window time period of suitability fostering endovascular thrombectomy. Stroke is a notable cause of morbidity and mortality around the globe. Greater understanding of the pathophysiology of neuronal damage in ischemic stroke has created interest in neuroprotection as a managing strategy. Neuroprotection is an increasingly recognized management strategy in ischemic stroke that promises to involvement clinicians in reducing stroke mortality rates and improving the quality of life of survivors.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalStroke Research & Therapy
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Ishaq Khan”
  • BylineArticles whose byline prints “Javeria Khan”
  • BylineArticles whose byline prints “Gazala Shams”
  • BylineArticles whose byline prints “Javed Shabbir”